Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages

  Fernando, Roshini ^a   Vonberg, Andrew ^b   Atkins, Stephen J ^a   Pietropaolo, Susan ^b   Pietropaolo, Massimo ^b   Smith, Terry J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD34 ANTIGEN; ISLET CELL ANTIGEN ICA512; ISLET CELL AUTOANTIGEN 69; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; ENDOCRINE DISEASE; FIBROBLAST; FIBROCYTE; GRAVES DISEASE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; SKIN FIBROBLAST;

ADULT; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; FIBROBLASTS; GRAVES DISEASE; HUMANS; MULTIPLE SCLEROSIS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;

EID: 84899960522     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3072     Document Type: Article

References (49)

1. Cardenas-Roldan J, Rojas-Villarraga A, Anaya JM. How do autoimmune diseases cluster in families A systemic review and metaanalysis. BMC Med. 2013;11:73.
2. Sellner J, Kallu ri SR, Cepok S, Hemmer B, Berthele A. Thyroid antibodies in aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis. Clin Endocrinol (Oxf). 2011; 75:271-272.
3. Pietropaolo M, Peakman M, Pietropaolo SL, et al. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and nonorgan-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J Autoim mun. 1998;11:1-10.
4. Trajkovski M, Mziaut H, Schubert S, Kalaidzdis Y, Altkruger A, Solimena M. Regulation of insulin granule turnover in pancreatic-cells by cleaved ICA512. J Biol Chem . 2008;48:33719-33729.
5. KargesW,Hammond-McKibben D, Gaedigk R, Shibuya N, Cheung R, Dosch HM. Loss of self-tolerance to ICA69 in nonobese diabetic mice. Diabetes. 1997;10:1548-1556.
6. Kawasaki E, Yu L, Gianni R, et al. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J Clin Endocrinol Metab. 1997;2:3 75-380.
7. Pietropaolo M, Castan o L, Babu S, et al. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest. 1993;1:359-371.
8. PietropaoloM,Towns R, Eisenbarth GS. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med. 2012;10:1-1 8.
9. Baekkeskov S Aanstoot H Christgau S et al. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase Nature. 1990 347: 151-156.
10. Palmer JP, AsplinCM,Clemons P, et al. Insulin antibodies in insulindependent diabetics before insulin treatment. Science. 1983;222: 1337-1339.
11. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 1994;13:505-514.
12. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (SIc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA. 2007;104:17040-17045.
13. Abramson J, Giruad M, Benoist C, Mathis D. Aire's partners in the molecular control of immunological tolerance. Cell. 2010;140:123-135.
14. Gardner JM, DeVoss JJ, Friedman RS, et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science. 2008;321: 843-847.
15. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define anewleukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71-81.
16. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166:7556-7562.
17. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998;160:419-425.
18. Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-processing cell capable of priming naïve T cells in situ. Proc Natl Acad Sci USA. 1997;94:6307-6312.
19. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circu lating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol. 2003;171:380-389.
20. Phillips RJ, BurdickMD,HongK, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114:438-446.
21. Piling D, Fan T, Kaul B, Gomer RH. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrop hages, and fibroblasts. PLoS One. 2009;4:e7475.
22. Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-and peroxisome proliferator-activated receptor-. J Biol Chem. 2007;282:22910-22920.
23. Douglas RS, Afifyan NF, Hwang CJ, et al. Increased generation of fibrocytes in thyroid-associated ophthalmopathy, J Clin Endocrinol Metab. 2010;95:430-438.
24. Smith TJ, Padovani-Claudio DA, Raychaudhuri N, et al. Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves'disease. J Clin Endocrinol Metab. 2011;96:3827-3837.
25. Fernando R, Atkins S, Raychaudhuri N, et al. Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci USA. 2012;109:7427-7432.
26. Xie J, Zhang B, Lan MS, Notkins AL. Genomic structure of promoter sequence of the insulin-dependent diabetes mellitus autoantigen, IA-2 (PTPRN). Genomics. 1998;54:338-343.
27. Friday RP, Pietropaolo SL, Profozich J, Trucco M, Pietropaolo M. Alternative core promoters regulate tissue-specific transcription from the autoimmune diabetes-related ICA1 (ICA69) gene locus. J Biol Chem. 2003;278:853-863.
28. Smith TJ, Koumas L, Gagnon A, et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endo Metab. 2002;87:385-3 92.
29. Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab. 1995; 80: 2620-2625.
30. Tsui S Fernando R Chen B Smith TJ. Divergent Sp1 protein levels may underlie differential expression of UDP glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves'disease J Biol Chem. 2011 286 24487-24499.
31. Li B, Smith TJ. Divergent expression of IL-1 receptor antagonists in CD34-fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contri bution of fibrocytes to orbital inflammation. J Clin Endocrinol Metab. 2013;98:2783-2790.
32. Mziaut H, Trajkovski M, Kersting S, et al. Synergy of glucose and growth hormone signaling in islet cells through ICA512 and STAT5. Nat Cell Biol. 2006;8:435-445.
33. Harashima S, Clark A, Christie MR, Notkins AL. The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle numbe r and insulin secretion. Proc Natl Acad Sci USA. 2005;102:8704-8709.
34. Solimena M, Dirkx R Jr., Hermel JM, et al. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J. 1996;15:2102-2114.
35. Martin S, Kardorf J, Schulte B, et al. Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia. 1995;38:351-355.
36. Song A, Winer S, Tsui H, et al. Deviation of islet autoreactivity to cryptic epitopes protects NOD mice from diabetes. Eur J Immunol. 2003;33:546-555.
37. Morran MP, Casu A, Arena VC, et al. Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type I diabetes. Endocrinology. 2010;151: 2528-2537.
38. Chen C, Bergerot I, Elliott JF, et al. Evidence that a peptide spanning the B-C junction of proinsulin is an early auto-antigen epitope in the pathogenesis of type I diabetes. J Immunol. 2001; 167:4926-4935.
39. Galligan CL, Siminovitch KA, Keystone EC, Bykerk V, Perez OD, Fish EN. Fibrocyte activation in rheumatoid arthritis.Rheum. 2010; 49:640-651.
40. WangCH,HuangCD,LinHC,et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Repir Crit Care Med. 2008;178:583-591.
41. Bucala, R. Circulating fibrocytes: Cellular basis for NSF. J Am Coll Radiol. 2008;5:36-39.
42. Gillespie EF, Papageorgiou K, Fernando R, et al. Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy l eads to chemokine production. J Clin Endocrinol Metab. 2012;5:E740-E746.
43. Nakajima K, Wu G, Sakudo A, Onadera T, Takeyama N. Distinct subcellular localization of three isoforms of insulin oma-associated protein 2-in neuroendocrine tissues. Life Sci. 2011;88:798-802.
44. Spitzenberger F, Pietropaolo S, Verkade P, et al. Islet cell autoantigen of 69 kDa is an arfaptin-related prot ein associated with the Golgi complex of insulinoma INS-1 cells. J Biol Chem. 2003;278:26166-26173.
45. Pilon M, Peng X-R, Spence AM, Plasterk RHA, Dosch HM. The diabetes autoantigen ICA69 an d its Caernorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretion. Mol Biol Cell. 11:3277-3288.
46. Kanasaki K, Taduri G, Koya D. Diabetic nephropathy: The role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol. 2013;4:1-15.
47. Kerokoski P, Ilonen J, Gaedigk R, et al. Production of the islet cell antigen ICA69 (p69) with bac ulovirus expression system: analysis with a solid-phase time-resolved fluorescence method of sera from patients with IDDM and rheumatoid arthritis. Autoimmunity. 1999;29:281-289.
48. Lin WR, Inatomi O, Lee CY, et al. Bone marrow-derived cells contribute to cerulean-induced pancreatic fibrosis in the mouse. Int J Exp Pathol. 2012;93:130-138.
49. Gordon TP, Cavill D, Neufing P, Zhang YJ, Pietropaolo M. ICA69 autoantibodies in primary Sjögren's syndrome. Lupus. 2004;13: 483-484.